Bristol-Myers Squibb Co - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BMY New York 2834 https://www.bms.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bristol-Myers Squibb Co

Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers - Dec 10th, 2018 12:00 am
Is Bristol Myers Squibb Co. (BMY) A Good Stock To Buy According To Hedge Funds? - Dec 8th, 2018 6:09 pm
Could These Be the Next 2 Biotech Buyouts? - Dec 8th, 2018 3:36 pm
Bristol-Myers Squibb (BMY) Stock Moves -0.32%: What You Should Know - Dec 7th, 2018 3:45 pm
CEO of Chapel Hill firm talks 2 new partnerships with big pharma - Dec 7th, 2018 2:42 pm
Mallinckrodt (MNK) to Separate Generics & Branded Businesses - Dec 7th, 2018 1:14 pm
The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut - Dec 7th, 2018 6:04 am
Bristol-Myers Squibb Announces Dividend Increase - Dec 6th, 2018 2:15 pm
Bristol-Myers Stock Is Rising on an Analyst Upgrade - Dec 6th, 2018 8:29 am
This stable value stock is built to weather market storms - Dec 5th, 2018 3:33 pm
Roche's Tecentriq Combination Gets Priority Review by FDA - Dec 5th, 2018 6:45 am
See what the IHS Markit Score report has to say about Bristol-Myers Squibb Co. - Dec 5th, 2018 6:00 am
Bristol-Myers Squibb to Announce Results for Fourth Quarter 2018 on January 24 - Dec 5th, 2018 4:59 am
J&J Strikes Deal with argenx to Co-Develop Cancer Antibody - Dec 4th, 2018 2:58 pm
Roche Announces Positive Data on Venclexta/Venclyxto at ASH - Dec 4th, 2018 12:39 pm
Renal Cell Carcinoma: Opportunity for Bristol-Myers Squibb - Dec 4th, 2018 7:01 am
The Zacks Analyst Blog Highlights: Shoe Carnival, On Deck, DXP, Arch Coal and Bristol-Myers - Dec 4th, 2018 6:57 am
Melanoma: BMY’s Growing Opportunity in Fiscal 2018 - Dec 4th, 2018 5:31 am